Company Data
TriSalus Life Sciences Inc.
Ticker
TLSI
Current Price
$5.77 0.87%
Market Cap
$175.9M
Price Target
Refer to Report
Volume
74.0K
52wk Range
$3.5 - $10.42
Overview
TriSalus Life Sciences®was created to develop and commercialize an innovative approach for the treatment of liver and pancreatic tumors. Our platform approach addresses immune dysfunction in liver and pancreatic tumors by combining immunotherapy drugs with highly effective drug delivery technology. Our company¿s heritage is in the development of devices for our Pressure-Enabled Drug Delivery¿ (PEDD¿) method. Building on this history, we launched our new platform in 2020 with the acquisition of SD-101. SD-101 is an investigational toll-like receptor 9 (TLR9) agonist with the potential to modulate the immune system to enable immunotherapy.